Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 132, Issue 1
July 5 2018
Issue Cover

Table of Contents

BLOOD COMMENTARIES

CLINICAL TRIALS AND OBSERVATIONS
Getting to transplant in Hodgkin lymphoma: BVB
Clinical Trials & Observations
Leo I. Gordon
View Articletitled, Getting to transplant in Hodgkin lymphoma: BVB
Lymphoid Neoplasia
The FLIPI nowadays: validation and modification
Eva Hoster
View Articletitled, The FLIPI nowadays: validation and modification
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
CEP: a new β2 integrin ligand in inflamed tissue
Markus Sperandio
View Articletitled, CEP: a new β<sub>2</sub> integrin ligand in inflamed tissue
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
HLH: genomics illuminates pathophysiological diversity
Bianca Tesi,Yenan T. Bryceson
View Articletitled, HLH: genomics illuminates pathophysiological diversity
Red Cells, Iron, and Erythropoiesis
Phenotyping rare hepcidin deficiency
Edouard Bardou-Jacquet
View Articletitled, Phenotyping rare hepcidin deficiency

SPECIAL REPORT

Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil
Clinical Trials & Observations
Charles Herbaux,Reid Merryman,Steven Devine,Philippe Armand,Roch Houot,Franck Morschhauser,Bradley Haverkos
View Articletitled, Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil

BLOOD SPOTLIGHT

Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?
Clinical Trials & Observations
Antonino Carbone,Annunziata Gloghini,Carmelo Carlo-Stella
View Articletitled, Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?

REVIEW ARTICLE

Novel therapeutics for hemophilia and other bleeding disorders
Clinical Trials & Observations
Michael U. Callaghan,Robert Sidonio,Steven W. Pipe
View Articletitled, Novel therapeutics for hemophilia and other bleeding disorders

HOW I TREAT

How and when I do allogeneic transplant in CLL
Clinical Trials & Observations
John G. Gribben
View Articletitled, How and when I do allogeneic transplant in CLL

CLINICAL TRIALS AND OBSERVATIONS

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma
Clinical Trials & Observations
Ann S. LaCasce,R. Gregory Bociek,Ahmed Sawas,Paolo Caimi,Edward Agura,Jeffrey Matous,Stephen M. Ansell,Howland E. Crosswell,Miguel Islas-Ohlmayer,Caroline Behler,Eric Cheung,Andres Forero-Torres,Julie Vose,Owen A. O’Connor,Neil Josephson,Yinghui Wang,Ranjana Advani
View Articletitled, Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma
Supplemental data

LYMPHOID NEOPLASIA

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy
Clinical Trials & Observations
Emmanuel Bachy,Matthew J. Maurer,Thomas M. Habermann,Bénédicte Gelas-Dore,Delphine Maucort-Boulch,Jane A. Estell,Eric Van den Neste,Réda Bouabdallah,Emmanuel Gyan,Andrew L. Feldman,Joan Bargay,Alain Delmer,Susan L. Slager,Maria Gomes da Silva,Olivier Fitoussi,David Belada,Hervé Maisonneuve,Tanin Intragumtornchai,Stephen M. Ansell,Thierry Lamy,Peggy Dartigues,Brian K. Link,John F. Seymour,James R. Cerhan,Gilles Salles
View Articletitled, A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy
Supplemental data
The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma
Clinical Trials & Observations
Leo Rasche,Edgardo J. Angtuaco,Terri L. Alpe,Grant H. Gershner,James E. McDonald,Rohan S. Samant,Manoj Kumar,Rudy Van Hemert,Joshua Epstein,Shayu Deshpande,Ruslana Tytarenko,Shmuel Yaccoby,Jens Hillengass,Sharmilan Thanendrarajan,Carolina Schinke,Frits van Rhee,Maurizio Zangari,Brian A. Walker,Bart Barlogie,Gareth J. Morgan,Faith E. Davies,Niels Weinhold
View Articletitled, The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma
Supplemental data

MYELOID NEOPLASIA

Tyrosine kinase inhibitor–induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors
Silvia Maifrede,Margaret Nieborowska-Skorska,Katherine Sullivan-Reed,Yashodhara Dasgupta,Paulina Podszywalow-Bartnicka,Bac Viet Le,Martyna Solecka,Zhaorui Lian,Elizaveta A. Belyaeva,Alina Nersesyan,Marcin M. Machnicki,Monika Toma,Nicolas Chatain,Malgorzata Rydzanicz,Huaqing Zhao,Jaroslav Jelinek,Katarzyna Piwocka,Tomasz Sliwinski,Tomasz Stoklosa,Rafal Ploski,Thomas Fischer,Stephen M. Sykes,Steffen Koschmieder,Lars Bullinger,Peter Valent,Mariusz A. Wasik,Jian Huang,Tomasz Skorski
View Articletitled, Tyrosine kinase inhibitor–induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors
Supplemental data

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

Oxidative modifications of extracellular matrix promote the second wave of inflammation via β2 integrins
Valentin P. Yakubenko,Kui Cui,Christopher L. Ardell,Kathleen E. Brown,Xiaoxia Z. West,Detao Gao,Samantha Stefl,Robert G. Salomon,Eugene A. Podrez,Tatiana V. Byzova
View Articletitled, Oxidative modifications of extracellular matrix promote the second wave of inflammation via β<sub>2</sub> integrins
Supplemental data
Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis
Ivan K. Chinn,Olive S. Eckstein,Erin C. Peckham-Gregory,Baruch R. Goldberg,Lisa R. Forbes,Sarah K. Nicholas,Emily M. Mace,Tiphanie P. Vogel,Harshal A. Abhyankar,Maria I. Diaz,Helen E. Heslop,Robert A. Krance,Caridad A. Martinez,Trung C. Nguyen,Dalia A. Bashir,Jordana R. Goldman,Asbjørg Stray-Pedersen,Luis A. Pedroza,M. Cecilia Poli,Juan C. Aldave-Becerra,Sean A. McGhee,Waleed Al-Herz,Aghiad Chamdin,Zeynep H. Coban-Akdemir,Shalini N. Jhangiani,Donna M. Muzny,Tram N. Cao,Diana N. Hong,Richard A. Gibbs,James R. Lupski,Jordan S. Orange,Kenneth L. McClain,Carl E. Allen
View Articletitled, Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease
Kam Sandhu,Kaledas Flintoff,Mark D. Chatfield,Jeannette L. Dixon,Louise E. Ramm,Grant A. Ramm,Lawrie W. Powell,V. Nathan Subramaniam,Daniel F. Wallace
View Articletitled, Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease
Supplemental data

BLOOD WORK

T-cell prolymphocytic leukemia negative for surface CD3 and CD45
Beenu Thakral,Sa A. Wang
View Articletitled, T-cell prolymphocytic leukemia negative for surface CD3 and CD45
Concurrent JAK2 mutation and isolated del(5q) associated with marrow fibrosis and small hypo/monolobated megakaryocytes
Rosemarie Tremblay-LeMay,Hong Chang
View Articletitled, Concurrent <em>JAK2</em> mutation and isolated del(5q) associated with marrow fibrosis and small hypo/monolobated megakaryocytes
All Issues

Advertisement intended for health care professionals

Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma
Itacitinib for Prevention of Graft-Versus-Host Disease and Cytokine Release Syndrome in Haploidentical Transplantation
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation
Prothrombotic Antibodies Targeting the Spike Protein's Receptor-Binding Domain in Severe COVID-19
The Contribution of the Monocyte‐Macrophage Lineage to Immunotherapy Outcomes

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals